Edge Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Edge Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-275	Closed	-$34K	–	676
2020 Q2	$34K	Hold	275	–	–	0.01%	307
2020 Q1	$24K	Hold	275	–	–	0.01%	297
2019 Q4	$29K	Hold	275	–	–	0.01%	301
2019 Q3	$31K	Hold	275	–	–	0.01%	297
2019 Q2	$48K	Hold	275	–	–	0.01%	262
2019 Q1	$46K	Hold	275	–	–	0.01%	246
2018 Q4	$27K	Hold	275	–	–	0.01%	300
2018 Q3	$48K	Hold	275	–	–	0.01%	261
2018 Q2	$38K	Hold	275	–	–	0.01%	278
2018 Q1	$31K	Buy	275 +75	+38%	+$9.43K	0.01%	264
2017 Q4	$26K	Buy	+200	New	+$23.5K	0.01%	289

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Edge Wealth Management's GWPH Position: Q3 2020 in Review

Edge Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 275 shares — an estimated $34K sold.

Edge Wealth Management first reported a position in GWPH in Q4 2017 and held it in 11 quarters. The position peaked at $48K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Edge Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Edge Wealth Management sold 275 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $34K.
Edge Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 11 quarters.
Edge Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $48K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.